AVALIDE
SANOFI-AVENTIS CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of AVALIDE in Canada?
Yes. AVALIDE 12.5MG 150MG has an active shortage reported to Health Canada (last updated October 30, 2026).
When will AVALIDE be available again?
The manufacturer's estimated resolution date is December 18, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-12-18
~36 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02241818
Strength
12.5MG 150MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
HYDROCHLOROTHIAZIDE IRBESARTAN
Tier
Unrated
Last Updated
2026-10-30
Reason for Shortage
Other (Please describe in comments)
Other Products from SANOFI-AVENTIS CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02464349
10MCG · DIN 02464276
20MCG · DIN 02464284
100UNIT · DIN 02469901
100UNIT · DIN 02469898
100UNIT · DIN 02469871
0.58MG · DIN 02254506
500UNIT · DIN 02422913
3000UNIT · DIN 02422956
2000UNIT · DIN 02422948
1000UNIT · DIN 02422921
4000UNIT · DIN 02448157